Brief: NW Bio enters into agreement with Woodford for $30 mln of equity funding
21/10/2015 17:00
Oct 21 (Reuters) - Northwest Biotherapeutics Inc NWBO.O : * Nw bio has entered into an agreement for $30 million of new equity funding from Woodford Investment Management * Woodford will purchase $30 million of the company's common stock at $5.50 per share, for a total of 5.5 million shares * Says in connection with financing, company has issued 0.7 million shares to Cognate Bioservices * Purchase by Woodford raises Woodford's total holdings to 25.9 million shares, or about 28.1% of the company * Source text for Eikon ID:nPn7vXNBZ * Further company coverage NWBO.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Northwest Biotherapeutics
See all newsBrief: Northwest Biotherapeutics And The UK National Health Service Blood And Transplant Announce Collaboration To Support Dcvax®-L Production
Brief: Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
Brief: Northwest Biotherapeutics Provides Update On Near Term Plans For Submission Of Marketing Authorization Application
Brief: Northwest Biotherapeutics And Advent Bioservices Announce Receipt Of License For Commercial Manufacturing At Sawston, U.K. Facility
Brief: Northwest Biotherapeutics Announces That It Has No Banking Relationship With SVB